Elmira Safarova is a dynamic and accomplished executive in the pharmaceutical industry and biotech startups. With extensive international experience and a deep understanding of science, R&D, and business development, she is a passionate leader who thrives in a dynamic culture. Elmira's entrepreneurship and creativity allow her to take on complicated projects with an entrepreneurial approach, and she has a solid understanding of the drug R&D process, driving execution and operations.

Elmira holds a master's degree in Biochemistry and Veterinary Medicine from the Department of Biology at the Moscow Veterinary Academy, a Ph.D. in Molecular Biology from the Institute of Molecular Genetics, and has also studied Business/Managerial Economics at Lomonosov Moscow State University and completed a specialization in Entrepreneurship/Entrepreneurial Studies at Wharton Online.

She has held several key positions in some of the major pharmaceutical companies across the world, such as Director of Science at Biomedical cluster at Skolkovo Foundation, Director General, BIND RUS LLC at BIND Therapeutics, BD& Investments Manager, R&D External Alliances at AstraZeneca, Medical Advisor, and R&D manager at Johnson&Johnson, and Head of Bioscreening Lab at Asinex.

Elmira's skills in people management, strategy development, organizational, analytical, and problem-solving skills, combined with her strong communication and relationship development abilities, make her a valuable asset to any company.